HPV Testing and PAP Test Market

Global HPV Testing and PAP Test Market Size, Trends & Analysis- Forecasts to 2026 By Test Type (HPV Test and PAP Test), By Application (Cervical Cancer Screening and Vaginal Cancer Screening), By End-User (Hospitals & Clinics, Laboratories, Other End Users), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 18 2024 with the latest and most recent market numbers

HPV Testing and PAP Test Market Size

The Global HPV Testing and PAP Test Market is projected to grow at a CAGR value of 30.2% from 2021 to 2026.

HPV testing, sometimes known as PAP test, is a cancer diagnostic test which can be used to detect chronic tumours in cervix and breast cancer. The test detects the presence of a tumorous cells in the body, which can lead to ovarian cancer in some people. The rise in the prevalence of cervical cancer among women is expected to fuel the market throughout the forecast period.

The market will grow rapidly owing to an increasing number of cervical cancer cases and rising ageing population, as well as increasing awareness of cancer screening programmes and rising government initiatives and support programs. The market for HPV testing and PAP tests is also driven by technological developments in cancer therapy, a rise in the number of cervical cancer screening schemes, and an increased rate of ovarian cancer.

Cervical cancer is the 4th most prevalent cancer in women, and as per the World Health Organization, with just an anticipated 3.1 million new cases in 2018, representing for 6.6 percent of all female cancers. Cervical cancer is responsible for about 90% of fatalities in middle- and low-income nations.

One of the key factors likely to boost the market for HPV testing and PAP test over the forecast period is rising demand for technologically advanced screening treatments for detecting cervical and vaginal malignancies. The market for HPV testing and PAP tests is likely to be driven by launch of improved technologies such as the invention of HPV-type 16 E7-specific human immunological kits used in non-HLA2 types, cobas system licenses, and the use of different molecular markers in screening processes.

The COVID had a negative impact on the HPV testing and PAP test market. Many discretionary medical treatments, including cancer screening schedules, have been put on hold due to immediate COVID-19 priority actions launched, and in order to prioritise other urgent needs and reduce the risk of COVID-19 spreading. As a consequence, cancer screening tests had dropped significantly.

global hpv testing and pap test market

HPV Testing and PAP Test Market: By Test Type

Based on various types of testing, the market is segmented into HPV test and PAP test. The HPV test segment is expected to grow the fastest in the HPV testing and PAP test market from 2021 to 2026. This is attributed to the introduction of novel tests and growing government programs for effective HPV screenings.

HPV evaluations are based on DNA and allow for the identification of various influenza viruses in a specimen. During initial evaluation, HPV tests aid in the identification of aberrant cells which may develop into malignant cells. This aids in disease prevention by enabling healthcare providers to choose from a variety of therapeutic and/or preventive measures.

HPV Testing and PAP Test Market: By Application Type

The market can be segmented into vaginal cancer screening and cervical cancer screening based on the kinds of applications available in the market. The cervical cancer segment is expected to hold a larger share as compared to other segment because of a growing societal awareness of the benefits of early tumor detection and rising number of government funding programs and awareness initiatives.

HPV Testing and PAP Test Market: By End-User

Based on the end-users, the market is divided into hospitals & clinics, laboratories, and other end users. The hospitals & clinics segment is expected to hold a larger share as compared to other segment because they are primary healthcare sites for the diagnosis and treatment of all illnesses, particularly HPV infections and uterine cancer. Moreover, increased demand for clinics and hospitals with expanded diagnostic services has increased as a result of rising healthcare expenditures worldwide and ongoing developments in the healthcare business. As a result, a number of hospitals in key sectors have begun to use technologically enhanced alternatives in order to give more efficient and precise outcomes.

asia pacific hpv testing and pap test market

HPV Testing and PAP Test Market By Region

As per the geographical analysis, the HPV testing and PAP test market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central & South America (Brazil, Argentina, and Rest of Central and South America).

North America (the United States, Canada, and Mexico), will have a dominant share in the HPV testing and PAP test market from 2021 to 2026. as a result of a growth in the number of cervical cancers and diagnostic methods. Furthermore, during the forecast period, favourable regulatory laws in North America are likely to drive the total market. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) for breast and cervical cancer screenings has aided the overall industry growth in the United States.

Moreover, the Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific), region is expected to be the fastest growing segment in the HPV testing and PAP test market during the forecast period. The high prevalence of HPV and genital cancer in key nations like Japan, China, and India is accountable for the rapid growth in the market.

HPV Testing and PAP Test Market Share and Competitor Analysis

Abbott Laboratories, Qiagen N. V., Becton, Dickinson and Company, Quest Diagnostics, Hologic Inc., Roche, Arbor Vita Corporation, Femasys Inc., Onco Health Corporation, Seegene Inc. among others are the key players in the HPV testing and PAP test market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 HPV Testing and PAP Test Industry Overview, 2020-2026

2.1.1 Industry Overview

2.1.2 Test Type Overview

2.1.3 End-User Overview

2.1.4 Application Overview

2.1.6 Regional Overview

Chapter 3 HPV Testing and PAP Test Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2020-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Advancements in the cancer diagnostic domain

3.3.2 End-User Challenges

3.3.2.1 Lack of access to advanced healthcare facility in third world countries

3.4 Prospective Growth Scenario

3.4.1 Test Type Growth Scenario

3.4.2 End-User Growth Scenario

3.4.3 Application Growth Scenario

3.5 COVID-19 Influence over End-User Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 End-User Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 HPV Testing and PAP Test Market, By Test Type

4.1 Test Type Outlook

4.2 HPV Test

4.2.1 Market Size, By Region, 2020-2026 (USD Billion)

4.3 PAP Test

4.3.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 5 HPV Testing and PAP Test Market, By End-User

5.1 End-User Outlook

5.2 Hospitals & Clinics

5.2.1 Market Size, By Region, 2020-2026 (USD Billion)

5.3 Laboratories

5.3.1 Market Size, By Region, 2020-2026 (USD Billion)

5.4 Other End Users

5.4.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 6 HPV Testing and PAP Test Market, By Application

6.1 Cervical Cancer Screening

6.1.1 Market Size, By Region, 2020-2026 (USD Billion)

6.2 Vaginal Cancer Screening

6.2.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 7 HPV Testing and PAP Test Market, By Region

7.1 Regional outlook

7.2 North America

7.2.1 Market Size, By Country 2020-2026 (USD Billion)

7.2.2 Market Size, By Test Type, 2020-2026 (USD Billion)

7.2.3 Market Size, By End-User, 2020-2026 (USD Billion)

7.2.4 Market Size, By Application, 2020-2026 (USD Billion)

7.2.6 U.S.

7.2.6.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.2.4.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.2.4.3 Market Size, By Application, 2020-2026 (USD Billion)

7.2.7 Canada

7.2.7.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.2.7.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.2.7.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3 Europe

7.3.1 Market Size, By Country 2020-2026 (USD Billion)

7.3.2 Market Size, By Test Type, 2020-2026 (USD Billion)

7.3.3 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.4 Market Size, By Application, 2020-2026 (USD Billion)

7.3.6 Germany

7.3.6.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.3.6.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.6.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3.7 UK

7.3.7.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.3.7.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.7.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3.8 France

7.3.7.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.3.7.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.7.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3.9 Italy

7.3.9.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.3.9.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.9.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3.10 Spain

7.3.10.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.3.10.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.10.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3.11 Russia

7.3.11.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.3.11.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.11.3 Market Size, By Application, 2020-2026 (USD Billion)

7.4 Asia Pacific

7.4.1 Market Size, By Country 2020-2026 (USD Billion)

7.4.2 Market Size, By Test Type, 2020-2026 (USD Billion)

7.4.3 Market Size, By End-User, 2020-2026 (USD Billion)

7.4.4 Market Size, By Application, 2020-2026 (USD Billion)

7.4.6 China

7.4.6.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.4.6.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.4.6.3 Market Size, By Application, 2020-2026 (USD Billion)

7.4.7 India

7.4.7.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.4.7.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.4.7.3 Market Size, By Application, 2020-2026 (USD Billion)

7.4.8 Japan

7.4.7.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.4.7.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.4.7.3 Market Size, By Application, 2020-2026 (USD Billion)

7.4.9 Australia

7.4.9.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.4.9.2 Market size, By End-User, 2020-2026 (USD Billion)

7.4.9.3 Market Size, By Application, 2020-2026 (USD Billion)

7.4.10 South Korea

7.4.10.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.4.10.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.4.10.3 Market Size, By Application, 2020-2026 (USD Billion)

7.5 Latin America

7.5.1 Market Size, By Country 2020-2026 (USD Billion)

7.5.2 Market Size, By Test Type, 2020-2026 (USD Billion)

7.5.3 Market Size, By End-User, 2020-2026 (USD Billion)

7.5.4 Market Size, By Application, 2020-2026 (USD Billion)

7.5.6 Brazil

7.5.6.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.5.6.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.5.6.3 Market Size, By Application, 2020-2026 (USD Billion)

7.5.7 Mexico

7.5.7.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.5.7.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.5.7.3 Market Size, By Application, 2020-2026 (USD Billion)

7.5.8 Argentina

7.5.7.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.5.7.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.5.7.3 Market Size, By Application, 2020-2026 (USD Billion)

7.6 MEA

7.6.1 Market Size, By Country 2020-2026 (USD Billion)

7.6.2 Market Size, By Test Type, 2020-2026 (USD Billion)

7.6.3 Market Size, By End-User, 2020-2026 (USD Billion)

7.6.4 Market Size, By Application, 2020-2026 (USD Billion)

7.6.6 Saudi Arabia

7.6.6.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.6.6.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.6.6.3 Market Size, By Application, 2020-2026 (USD Billion)

7.6.7 UAE

7.6.7.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.6.7.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.6.7.3 Market Size, By Application, 2020-2026 (USD Billion)

7.6.8 South Africa

7.6.7.1 Market Size, By Test Type, 2020-2026 (USD Billion)

7.6.7.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.6.7.3 Market Size, By Application, 2020-2026 (USD Billion)

Chapter 8 Company Landscape

8.1 Competitive Analysis, 2020

8.2 Abbott Laboratories

8.2.1 Company Overview

8.2.2 Financial Analysis

8.2.3 Strategic Positioning

8.2.4 Infographic Analysis

8.3 Qiagen N. V.

8.3.1 Company Overview

8.3.2 Financial Analysis

8.3.3 Strategic Positioning

8.3.4 Infographic Analysis

8.4 Becton

8.4.1 Company Overview

8.4.2 Financial Analysis

8.4.3 Strategic Positioning

8.4.4 Infographic Analysis

8.5 Dickinson and Company

8.5.1 Company Overview

8.5.2 Financial Analysis

8.5.3 Strategic Positioning

8.5.4 Infographic Analysis

8.6 Quest Diagnostics

8.6.1 Company Overview

8.6.2 Financial Analysis

8.6.3 Strategic Positioning

8.6.4 Infographic Analysis

8.7 Hologic Inc

8.7.1 Company Overview

8.7.2 Financial Analysis

8.7.3 Strategic Positioning

8.7.4 Infographic Analysis

8.8 Roche

8.8.1 Company Overview

8.8.2 Financial Analysis

8.8.3 Strategic Positioning

8.8.4 Infographic Analysis

8.9 Arbor Vita Corporation

8.8.1 Company Overview

8.8.2 Financial Analysis

8.8.3 Strategic Positioning

8.8.4 Infographic Analysis

8.10 Femasys Inc

8.10.1 Company Overview

8.10.2 Financial Analysis

8.10.3 Strategic Positioning

8.10.4 Infographic Analysis

8.11 Onco Health Corporation

8.11.1 Company Overview

8.11.2 Financial Analysis

8.11.3 Strategic Positioning

8.11.4 Infographic Analysis

8.12 Other Companies

8.12.1 Company Overview

8.12.2 Financial Analysis

8.12.3 Strategic Positioning

8.12.4 Infographic Analysis

The Global HPV Testing and PAP Test Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the HPV Testing and PAP Test Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global HPV testing and PAP test market?

The global HPV testing and PAP test market is projected to grow from USD 4.01 billion in 2021 to reach 5.20 billion in 2026 with a CAGR value of 7.1% from 2021 to 2026.

Who are the major vendors in the HPV testing and PAP test market?

Which region has the highest market share in the HPV testing and PAP test market?

The North American region is estimated to hold the highest market share in the HPV testing and PAP test market.

What is the Covid-19 impact on future HPV testing and PAP test manufacturers?

The COVID had a negative impact on the HPV testing and Pap test market. Many discretionary medical treatments, including cancer screening schedules, have been put on hold due to immediate COVID-19 priority actions launched, and in order to prioritise other urgent needs and reduce the risk of COVID-19 spreading. As a consequence, cancer screening tests had dropped significantly.

What are the major drivers in the HPV testing and PAP test market?